InvestorsHub Logo
Followers 225
Posts 32268
Boards Moderated 3
Alias Born 10/10/2005

Re: None

Tuesday, 05/03/2016 11:06:53 AM

Tuesday, May 03, 2016 11:06:53 AM

Post# of 15274
An exploratory study on the effectiveness of "Calmare therapy" in patients with cancer-related neuropathic pain: A pilot study.


Lee SC1, Park KS1, Moon JY2, Kim EJ1, Kim YC1, Seo H1, Sung JK1, Lee da J3.

Author information

1Department of Anesthesiology and Pain Medicine, Seoul National University Hospital College of Medicine, Seoul, Republic of Korea.
2Department of Anesthesiology and Pain Medicine, Seoul National University Hospital College of Medicine, Seoul, Republic of Korea. Electronic address: jymoon0901@gmail.com.
3University Medical Center, De La Salle Health Sciences Institute, Dasmariñas, Cavite, Philippines.

Abstract

PURPOSE:

Calmare therapy (CT) has been suggested as a novel treatment for managing chronic pain. Recently, it was reported to show a positive therapeutic outcome for managing neuropathic pain condition. We performed an exploratory prospective study on the effectiveness of CT in patients with various types of cancer-related neuropathic pain (CNP).

METHOD:

We performed an open-labeled, single-arm, exploratory study on the effectiveness of CT in patients with various types of cancer-related neuropathic pain (CNP). The primary endpoint was a comparison of the 11-point Numerical Rating Scale (NRS) pain score at one month with the baseline score in each patient. Brief Pain Inventory (BPI) and consumption of opioid were also evaluated during follow-up period.

RESULTS:

CT significantly decreased NRS pain score at one month from baseline (p < 0.001) in 20 patients with chemotherapy-induced peripheral neuropathy (n = 6), metastatic bone pain (n = 7), and post-surgical neuropathic pain (n = 7). It also improved overall BPI scores, decreased consumption of rescue opioid (p = 0.050), and was found satisfactory by a half of patients (n = 10, 50.0%).

CONCLUSIONS:

Our preliminary results suggest that CT may be considered for cancer patients with various types of CNP. Large studies are necessary to confirm our findings and ascertain which additional CNP show positive response to CT.

Copyright © 2015 Elsevier Ltd. All rights reserved.

KEYWORDS:
Calmare therapy; Cancer pain; Neuropathic pain; Noninvasive approach; Pain management; Scrambler therapy
An exploratory study on the effectiveness of "Calmare therapy" in patients with cancer-related neuropathic pain: A pilot study. - PubMed - NCBI

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.